These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8521130)

  • 1. Are T1c tumors different from incidental tumors found at autopsy? The risk and reality of overdetection.
    Belville WD
    Semin Urol Oncol; 1995 Aug; 13(3):181-6. PubMed ID: 8521130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the incidence of latent prostate cancer detected at autopsy before and after the prostate specific antigen era.
    Konety BR; Bird VY; Deorah S; Dahmoush L
    J Urol; 2005 Nov; 174(5):1785-8; discussion 1788. PubMed ID: 16217287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The independent impact of extended pattern biopsy on prostate cancer stage migration.
    Master VA; Chi T; Simko JP; Weinberg V; Carroll PR
    J Urol; 2005 Nov; 174(5):1789-93; discussion 1793. PubMed ID: 16217288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate biopsy: who, how and when. An update.
    Djavan B; Milani S; Remzi M
    Can J Urol; 2005 Feb; 12 Suppl 1():44-8; discussion 99-100. PubMed ID: 15780165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer.
    Noguchi M; Stamey TA; McNeal JE; Yemoto CM
    J Urol; 2001 Jul; 166(1):104-9; discussion 109-10. PubMed ID: 11435833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection bias due to the effect of finasteride on prostate volume: a modeling approach for analysis of the Prostate Cancer Prevention Trial.
    Cohen YC; Liu KS; Heyden NL; Carides AD; Anderson KM; Daifotis AG; Gann PH
    J Natl Cancer Inst; 2007 Sep; 99(18):1366-74. PubMed ID: 17848668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database.
    Freedland SJ; Presti JC; Terris MK; Kane CJ; Aronson WJ; Dorey F; Amling CL;
    J Urol; 2003 Jun; 169(6):2129-35. PubMed ID: 12771734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epidemiology of prostate cancer part I: descriptive epidemiology.
    Brawley OW; Knopf K; Merrill R
    Semin Urol Oncol; 1998 Nov; 16(4):187-92. PubMed ID: 9858324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of first repeat biopsy cancer detection with suspected local stage prostate cancer.
    Fowler JE; Bigler SA; Miles D; Yalkut DA
    J Urol; 2000 Mar; 163(3):813-8. PubMed ID: 10687983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005.
    Adolfsson J; Garmo H; Varenhorst E; Ahlgren G; Ahlstrand C; Andrén O; Bill-Axelson A; Bratt O; Damber JE; Hellström K; Hellström M; Holmberg E; Holmberg L; Hugosson J; Johansson JE; Petterson B; Törnblom M; Widmark A; Stattin P
    Scand J Urol Nephrol; 2007; 41(6):456-77. PubMed ID: 17934985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection rate of histologically insignificant prostate cancer with systematic sextant biopsies and fine needle aspiration cytology.
    Hautmann SH; Conrad S; Henke RP; Erbersdobler A; Simon J; Straub M; Graefen M; Hautmann RE; Huland H
    J Urol; 2000 Jun; 163(6):1734-8. PubMed ID: 10799171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do clinically insignificant tumors of the prostate exist?
    Stamatiou K; Alevizos A; Mariolis A; Spiliopoulou C; Alevizou A; Bovis K; Sofras F
    Urol Int; 2008; 81(4):379-82. PubMed ID: 19077395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-specific antigen velocity at low prostate-specific antigen levels as screening tool for prostate cancer: results of second screening round of ERSPC (ROTTERDAM).
    Roobol MJ; Kranse R; de Koning HJ; Schröder FH
    Urology; 2004 Feb; 63(2):309-13; discussion 313-5. PubMed ID: 14972478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A study on parameters to predict tumor volume for stage T1c prostate cancers of Gleason score 6 or less].
    Shichiri Y; Egawa S; Kamoto T; Kakehi Y; Ogawa O; Yoshida O; Sumiyoshi Y; Akakura K; Arai Y
    Hinyokika Kiyo; 2000 Nov; 46(11):785-90. PubMed ID: 11193298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lead time of prostate cancer detected in population based screening for prostate cancer in Japan.
    Ito K; Yamamoto T; Miyakubo M; Takechi H; Ohi M; Shibata Y; Suzuki K
    J Urol; 2007 Oct; 178(4 Pt 1):1258-63; discussion 1263-4. PubMed ID: 17698107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of prostate cancer at different levels of serum prostate-specific antigen (PSA) and different free: total PSA ratios in a consecutive series of men referred for prostate biopsies.
    Rydén L; Egevad L; Ekman P; Hellström M
    Scand J Urol Nephrol; 2007; 41(4):302-7. PubMed ID: 17763221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological parameters of radical prostatectomy for clinical stages T1c versus T2 prostate adenocarcinoma: decreased pathological stage and increased detection of transition zone tumors.
    Jack GS; Cookson MS; Coffey CS; Vader V; Roberts RL; Chang SS; Smith JA; Shappell SB
    J Urol; 2002 Aug; 168(2):519-24. PubMed ID: 12131301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical staging of prostate cancer: a computer-simulated study of transperineal prostate biopsy.
    Crawford ED; Wilson SS; Torkko KC; Hirano D; Stewart JS; Brammell C; Wilson RS; Kawata N; Sullivan H; Lucia MS; Werahera PN
    BJU Int; 2005 Nov; 96(7):999-1004. PubMed ID: 16225516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lesions predictive for prostate cancer in a screened population: first and second screening round findings.
    Postma R; Roobol M; Schröder FH; van der Kwast TH
    Prostate; 2004 Nov; 61(3):260-6. PubMed ID: 15368469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Needle biopsies on autopsy prostates: sensitivity of cancer detection based on true prevalence.
    Haas GP; Delongchamps NB; Jones RF; Chandan V; Serio AM; Vickers AJ; Jumbelic M; Threatte G; Korets R; Lilja H; de la Roza G
    J Natl Cancer Inst; 2007 Oct; 99(19):1484-9. PubMed ID: 17895474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.